Metraipolis › archive › dc_44f5b59ee0bc
Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease — Europe PMC PMID:41788683
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41788683
- DOI
- 10.3389/fnut.2026.1730695
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T16:32:30.856Z
- SHA-256 of the archived text
911a84bbd4a70d0dd29630da42184118b71ce6cf825f1bdb12ac52706e5f781b- Stable URL of this page
https://metraipolis.com/documento/dc_44f5b59ee0bc
How to cite
Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease — Europe PMC PMID:41788683 — Europe PMC (en), https://europepmc.org/article/MED/41788683 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44f5b59ee0bc (Metraipolis archive dc_44f5b59ee0bc, sha256 911a84bbd4a70d0dd29630da42184118b71ce6cf825f1bdb12ac52706e5f781b)
BibTeX
@misc{dc44f5b59ee0bc,
title = {Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease — Europe PMC PMID:41788683},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41788683},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44f5b59ee0bc; sha256 911a84bbd4a70d0dd29630da42184118b71ce6cf825f1bdb12ac52706e5f781b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41788683. Agents can read the archived copy with the MCP tool read_document.